Huntington Study Group Launches New CME Accredited Interactive Case Study Courses

The Huntington Study Group (HSG), a world leader in spearheading research and conducting clinical trials in Huntington disease (HD), has launched a new offering to its acclaimed CME4HD^TM online learning curriculum. The 2020 edition of CME4HD^TM features seven interactive case studies that build upon the faculty lecture content launched last year (2019). Learners are presented with real world scenarios that healthcare professionals may encounter working with patients or families at various stages of Huntington disease, and answer questions to determine the best course of action for the scenario. 

“The vision of CME4HD is to show healthcare professionals and providers a way to care for HD patients and families using currently available interventions,” said Dr. Mary Edmondson, Chair of the HSG Provider Education Committee. “Through this program, we hope to inspire them to learn more about this fascinating and challenging patient population and their remarkable families, and to “spotlight” clinical problems that, if managed well, have a great impact in terms of the quality of life for patients and a lasting effect within the extended family.”

Learners can earn up to 1.75 total credits at no cost (CME, CNE, or IPCE). Users with existing HSG Litmos accounts can login and take the new courses at their leisure. New users can sign up for a complimentary HSG Litmos learning account by following the steps on the HSG website (https://huntingtonstudygroup.org/cme4hd-online/). This activity has been supported through an independent educational grant from Genentech. 

“The Huntington Study Group has long been seen as a leader in education on Huntington disease for healthcare professionals. We are proud to continue offering a high quality program like CME4HD to the provider community,” said Dr. Andrew Feigin, HSG Chair. “The efforts of Dr. Edmondson and the Provider Education Committee are reflective of the passion we all have to improve the quality of care for HD patients and families.”

About HSG

Founded in 1993 in Rochester, NY, the Huntington Study Group (HSG) is a not-for-profit organization comprised of the world’s first and largest collaborative network of experts in Huntington disease. The mission of the HSG is seeking treatments that make a difference for those affected by HD. With more than 700 credentialed HD experts at over 125 HSG credentialed research sites worldwide, the HSG is a leader in conducting clinical trials for HD. The HSG also offers educational services like CME4HD ™ for healthcare professionals and care providers on treating patients with HD. For more information, visit our website www.huntingtonstudygroup.org.

About CME4HD^TM

CME4HD has been planned and implemented by North American Center for Continuing Medical Education, LLC (NACCME) and the Huntington Study group. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.